The $10 Billion Acquisition Is Set, as Vertex Pharmaceuticals Bets on a New Blue Ocean in Rare Endocrine Diseases Life Science
TransMedics Is Betting on Kidney Transplants and European Expansion Despite a 40% Stock Drop in Six Months, Yet Long-Term Prospects Remain Strong Life Science
Significant Improvement in AI Investment Returns Enhances Earnings Prospects, Bullish Logic for Blue-Chip UnitedHealth Is Reshaping Life Science
Pharmaceutical Giant AbbVie Makes a Major Bet on a New Immunotherapy, and Its Dividend Growth Record Attracts Income-Focused Investors Life Science
Small-Cap U.S. Stocks Trounce S&P 500 in First Half; Seven Top Small-Cap ETFs to Watch Financial Service, Life Science, Technology
Anthropic Launches Claude Science to Enter Life Sciences, AI Drug Discovery Stocks Tumble in Response Life Science
Insiders Sell Nearly $900,000 in Stock as Monterosa Medical Faces Key Clinical Data Test Life Science
